Most US neurologists prescribing multiple sclerosis drugs receive pharma industry payments
Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5…